Shell Asset Management CO Intercept Pharmaceuticals, Inc. Transaction History

Shell Asset Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$19.33 - $37.75 $38,022 - $74,254	-1,967 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$46.7 - $92.04 $513 - $1,012	11 Added 0.56%	1,967 $94,000
Q1 2020 May 11, 2020	SELL	$48.35 - $118.68 $1,402 - $3,441	-29 Reduced 1.46%	1,956 $123,000
Q4 2019 Feb 13, 2020	SELL	$57.36 - $124.1 $803 - $1,737	-14 Reduced 0.7%	1,985 $246,000
Q3 2019 Nov 12, 2019	SELL	$58.69 - $80.46 $997 - $1,367	-17 Reduced 0.84%	1,999 $133,000
Q2 2019 Aug 12, 2019	SELL	$77.77 - $120.68 $3,577 - $5,551	-46 Reduced 2.23%	2,016 $160,000
Q1 2019 May 09, 2019	BUY	$91.83 - $120.68 $189,353 - $248,842	2,062 New	2,062 $231,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.